Recent cerebrospinal fluid biomarker studies of Alzheimer’s disease

A systems biology approach to understanding atherosclerosis

(2010) Stephen A. Ramsey et al.   EMBO Molecular Medicine

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases

(2009) Guo Nan Yin et al.   BRAIN RESEARCH

Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis

(2009) Konstantinos Kazanis et al.   CLINICA CHIMICA ACTA

Quantitative Analysis of β-Amyloid Peptides Expressed in Human Cerebrospinal Fluid by an Improved Method of Antibody-Assisted Time-of-Flight Mass Spectrometry

(2009) Akira Matsumoto et al.   International Journal of Peptide Research and Therapeutics

Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid

(2009) Erik Portelius et al.   Neurodegenerative Diseases

S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10

(2009) Weiping Qin et al.   PLoS One

Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?

(2008) S. A. Carr et al.   CLINICAL CHEMISTRY

Application of Targeted Quantitative Proteomics Analysis in Human Cerebrospinal Fluid Using a Liquid Chromatography Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Tandem Mass Spectrometer (LC MALDI TOF/TOF) Platform

(2008) Sheng Pan et al.   JOURNAL OF PROTEOME RESEARCH

Selected reaction monitoring for quantitative proteomics: a tutorial

(2008) Vinzenz Lange et al.   Molecular Systems Biology

Structural and Quantitative Comparison of Cerebrospinal Fluid Glycoproteins in Alzheimer’s Disease Patients and Healthy Individuals

(2008) Carina Sihlbom et al.   NEUROCHEMICAL RESEARCH

Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: Candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease

(2008) Sang Min Jung et al.   NEUROSCIENCE LETTERS

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

(2008) Amanda G. Paulovich et al.   Proteomics Clinical Applications

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease

(2007) A.H. Simonsen et al.   NEUROBIOLOGY OF AGING